ENTX vs RGNX: stock comparison and AI forecast
Entera Bio Ltd. (ENTX) and Regenxbio Inc. (RGNX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ENTX Entera Bio Ltd.
- Market Cap
- $518M
- P/E Ratio
- 9.1x
- Size
- small-cap
- AI Forecast
RGNX Regenxbio Inc.
- Price
- $7.71 -24.6% · 6M
- Market Cap
- $509M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ENTX and RGNX have similar market capitalizations ($518M and $509M).
- RGNX carries 2.15 times debt per unit of equity, against 1.68 times for ENTX.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ENTX | RGNX |
|---|---|---|
| Market Cap | $518M | $509M |
| P/E Ratio | 9.06x | – |
| P/B Ratio | 71.25x | 3.44x |
| EPS | $0.33 | $-3.09 |
| Book Value/Share | $0.04 | $2.24 |
| Revenue/Share | $0.00 | $2.23 |
| FCF/Share | $-0.06 | $-2.35 |
Profitability & Margins
| Metric | ENTX | RGNX |
|---|---|---|
| ROE | – | -118.4% |
| ROA | – | -37.6% |
| ROIC | -82.9% | -37.0% |
| Operating Margin | – | -99.8% |
| Net Margin | – | -118.8% |
| EBT Margin | – | -122.0% |
Financial Health
| Metric | ENTX | RGNX |
|---|---|---|
| Current Ratio | 8.98x | 4.74x |
| D/E Ratio | 1.68x | 2.15x |
| Financial Leverage | 2.68x | 3.15x |
| Interest Coverage | – | -124.8x |
| Working Capital | $17M | $253M |
Cash Flow
| Metric | ENTX | RGNX |
|---|---|---|
| Operating Cash Flow | -$11M | -$152M |
| Free Cash Flow | -$11M | -$155M |
| Capital Spending | -$70K | -$3M |
| FCF/Sales | – | -104.9% |
| CapEx/Sales | – | 1.8% |
Operational Efficiency
| Metric | ENTX | RGNX |
|---|---|---|
| Asset Turnover | 0.00x | 0.32x |
| Receivables Turnover | – | 17.3x |
| Fixed Assets Turnover | 0.0x | 1.6x |
| Days Sales Outstanding | – | 21 days |
Income Statement
| Metric | ENTX | RGNX |
|---|---|---|
| Total Revenue | $0.00M | $148M |
| Operating Income | -$14M | -$147M |
| Net Income | – | -$175M |
| R&D Expense | $9M | $234M |
| SG&A Expense | $550K | – |
| Cost of Goods Sold | $0.00M | – |
Dividend & Shareholder Information
| Metric | ENTX | RGNX |
|---|---|---|
| Shares Outstanding | 173M | 66M |
| EPS Growth | 32.0% | – |
ENTX vs RGNX: stock comparison and AI forecast
Which is bigger, ENTX or RGNX?
ENTX and RGNX have similar market capitalizations ($518M and $509M).
Which one does Intratio's AI model rank higher, ENTX or RGNX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.